ArticleOrthopaedic journal of sports medicine2025
Increased Deltoid Muscle Volume After Scope-Assisted Lower Trapezius Tendon Transfer.
Article in Orthopaedic journal of sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Scope-assisted lower trapezius tendon transfer (SALTT) has emerged as a viable treatment option for posterosuperior irreparable rotator cuff tears (PSIRCTs) due to its biomechanical advantages and favorable clinical outcomes. However, there is limited research on deltoid muscle volume (DMV) and muscle strength recovery after SALTT. Purpose: To evaluate the changes in DMV and its effect on clinical outcomes-including muscle strength after SALTT. Study Design: Case-control study; Level of evidence, 3. Methods: This retrospective study analyzed 54 patients with PSIRCT who underwent SALTT from January 2021 to January 2022, with a minimum follow-up of 2 years. The deltoid muscle area of each 2-dimensional axial magnetic resonance image was identified and segmented using ITK-SNAP automatic segmentation software. The 3-dimensional (3D) deltoid muscle model was generated by combining each segmented 2D axial image, and the volume was automatically calculated. The clinical assessment included shoulder pain, patient-reported outcome measures (PROMs), active range of motion (aROM), and muscle strength of aROM. Results: The postoperative clinical outcomes were significantly improved after SALTT. The postoperative body mass index-adjusted DMV (aDMV) showed a statistically significant increase compared with the preoperative aDMV. Based on the mean postoperative Constant score, 32 patients had scores above the mean (optimal function group), while 22 patients had scores below the mean (suboptimal function group). The pre-aDMV and post-aDMV in the optimal function group were significantly larger than those in the suboptimal function group. However, there was no significant difference in ΔaDMV (the difference between pre-aDMV and post-aDMV) between the 2 groups. A graft rupture occurred in 6 patients. The graft-intact group showed statistically significantly better outcomes than the graft-rupture group. Although there was no difference in pre-aDMV between the 2 groups, post-aDMV and ΔaDMV were significantly larger in the graft intact group. The ΔaDMV is significantly correlated with postoperative PROMs, aROM, and muscle strength. Conclusion: This study confirmed that the postoperative aDMV was significantly increased after SALTT, and the increase of aDMV was significantly associated with good clinical outcomes-including PROMs, aROM, and aROM strength. These findings contribute to understanding the mechanism of aROM strength recovery by demonstrating an increase in DMV after SALTT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.